Pharmaceutical Factory of Beijing Tongrentang Technology Development Co., Ltd.

Tongrentang is a time-honored brand in China's traditional Chinese medicine industry, founded in 1669 and with a history of more than 300 years. In August 1992, China Beijing Tongrentang Group Company was officially established. In June 1997, Beijing Tongrentang Co., Ltd. was grandly listed on the Shanghai Stock Exchange. In March 2000, Beijing Tongrentang Co., Ltd. carved out part of its high-quality assets to establish Beijing Tongrentang Technology Development Co., Ltd., which was listed on the Growth Enterprise Market of the Hong Kong Stock Exchange at the end of October of the same year. After listing, Tongrentang Technology has consistently maintained good performance and was officially transferred to the Main Board of the Hong Kong Stock Exchange on July 9, 2010, with stock code 01666. As a high-tech modern traditional Chinese medicine enterprise under Tongrentang Group integrating production, supply and sales, Tongrentang Technology insists on inheriting and carrying forward Tongrentang's royal pharmaceutical tradition, relies on modern pharmaceutical technology, takes "cultivating benevolence and virtue, benefiting the world and nurturing life" as its mission, adheres to the pharmaceutical characteristics of "unique formula, superior materials, exquisite craftsmanship and significant efficacy", and all production workshops are designed, renovated and operated strictly in accordance with GMP standards. It is renowned for its large production potential, rich dosage form reserves and good product quality. Not only have all production lines of our company passed national GMP certification, but we also have multiple production lines certified by Australia's TGA and Japan's Ministry of Health, Labour and Welfare, and the company passed ISO9001 quality system certification as early as 2003. Our company has purchased land in the Beijing Biopharmaceutical Industry Park in Daxing District and invested in the construction of a new logistics distribution center, a medicinal material pre-processing center, and liquid preparation and soft capsule production centers to further increase production capacity and ensure market supply. The products of Beijing Tongrentang Technology Development Co., Ltd. involve more than 20 dosage forms and more than 200 varieties, and there is a rich reserve of developed new products and new products under development. In recent years, according to market demand and changes, Beijing Tongrentang Technology Development Co., Ltd. has improved the technological content of its products, focused on secondary research, adopted new processes and new technologies such as sugar-free production, full-extraction concentrated pill technology, film coating of tablets, macroporous resin adsorption, spray drying, fluidized bed granulation, full-extraction concentration and ultrafine pulverization, and launched new products such as sugar-free Ganmao Qingre Granules, Liuwei Dihuang Concentrated Pills, various film-coated tablets, tablets, soft capsule dosage forms, etc., and has advanced production lines for tablets, soft capsules, concentrated pills, honey pills and granules to meet the different needs of patients. This reflects Tongrentang's business philosophy of being pragmatic and innovative and putting patients first. In the future, Beijing Tongrentang Technology Development Co., Ltd. will continue to be committed to the modernization of traditional Chinese medicine, improve existing traditional Chinese medicine products and develop natural drugs, gradually realize the modernization and internationalization of traditional Chinese medicine, expand the marketing network, and promote modern traditional Chinese medicine into the mainstream international pharmaceutical market.